Vicore Pharma Holding AB
STO:VICO

Watchlist Manager
Vicore Pharma Holding AB Logo
Vicore Pharma Holding AB
STO:VICO
Watchlist
Price: 7.91 SEK 1.67% Market Closed
Market Cap: 1.9B SEK
Have any thoughts about
Vicore Pharma Holding AB?
Write Note

Vicore Pharma Holding AB
Accounts Payable

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Vicore Pharma Holding AB
Accounts Payable Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Accounts Payable CAGR 3Y CAGR 5Y CAGR 10Y
Vicore Pharma Holding AB
STO:VICO
Accounts Payable
kr18.2m
CAGR 3-Years
-19%
CAGR 5-Years
24%
CAGR 10-Years
N/A
Biogaia AB
STO:BIOG B
Accounts Payable
kr49.3m
CAGR 3-Years
1%
CAGR 5-Years
8%
CAGR 10-Years
N/A
Bonesupport Holding AB
STO:BONEX
Accounts Payable
kr10.4m
CAGR 3-Years
-10%
CAGR 5-Years
-5%
CAGR 10-Years
N/A
Vitrolife AB
STO:VITR
Accounts Payable
kr190m
CAGR 3-Years
62%
CAGR 5-Years
36%
CAGR 10-Years
26%
Swedish Orphan Biovitrum AB (publ)
STO:SOBI
Accounts Payable
kr1.4B
CAGR 3-Years
20%
CAGR 5-Years
32%
CAGR 10-Years
N/A
BioArctic AB
STO:BIOA B
Accounts Payable
kr29.9m
CAGR 3-Years
28%
CAGR 5-Years
15%
CAGR 10-Years
N/A
No Stocks Found

Vicore Pharma Holding AB
Glance View

Market Cap
1.9B SEK
Industry
Biotechnology

Vicore Pharma Holding AB is a pharmaceutical company, which engages in the development of drugs with focus on interstitial lung diseases and related indications. The company is headquartered in Goeteborg, Vastra Gotalands. The company went IPO on 2015-12-10. The firm's portfolio contains small molecules with potential indications, including anti-inflammation, nerve generation and cardiovascular disease. The firm is a wholly owned subsidiary of Mintage Scientific AB.

VICO Intrinsic Value
2.94 SEK
Overvaluation 63%
Intrinsic Value
Price

See Also

What is Vicore Pharma Holding AB's Accounts Payable?
Accounts Payable
18.2m SEK

Based on the financial report for Jun 30, 2024, Vicore Pharma Holding AB's Accounts Payable amounts to 18.2m SEK.

What is Vicore Pharma Holding AB's Accounts Payable growth rate?
Accounts Payable CAGR 5Y
24%

Over the last year, the Accounts Payable growth was 14%. The average annual Accounts Payable growth rates for Vicore Pharma Holding AB have been -19% over the past three years , 24% over the past five years .

Back to Top